Literature DB >> 11526386

Immunotherapy of multiple sclerosis: where are we? Where should we go?

R Martin1, C S Stürzebecher, H F McFarland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11526386     DOI： 10.1038/ni0901-785

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  14 in total

Review 1.  New approaches to investigating heterogeneity in complex traits.

Authors:  R Bomprezzi; P E Kovanen; R Martin
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

Review 2.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 3.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 4.  Genomics and proteomics: role in the management of multiple sclerosis.

Authors:  Ludwig Kappos; Lutz Achtnichts; Frank Dahlke; Jens Kuhle; Y Naegelin; Rupert Sandbrink; Raija L P Lindberg
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

5.  Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells.

Authors:  Stacey D Finley; Deepti Gupta; Ning Cheng; David J Klinke
Journal:  Immunol Cell Biol       Date:  2010-05-18       Impact factor: 5.126

6.  [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.

Authors:  Lin Xie; Tomoteru Yamasaki; Naotsugu Ichimaru; Joji Yui; Kazunori Kawamura; Katsushi Kumata; Akiko Hatori; Norio Nonomura; Ming-Rong Zhang; Xiao-Kang Li; Shiro Takahara
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-29       Impact factor: 4.147

7.  Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.

Authors:  Timo Burster; Alexander Beck; Simone Poeschel; Anita Øren; Daniel Baechle; Michael Reich; Olaf Roetzschke; Kirsten Falk; Bernhard O Boehm; Sawsan Youssef; Hubert Kalbacher; Herman Overkleeft; Eva Tolosa; Christoph Driessen
Journal:  Immunology       Date:  2007-02-14       Impact factor: 7.397

8.  Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis.

Authors:  Monika Hofbauer; Solveigh Wiesener; Holger Babbe; Axel Roers; Hartmut Wekerle; Klaus Dornmair; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

9.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Early stage and long term treatment of multiple sclerosis with interferon-beta.

Authors:  Angela Applebee; Hillel Panitch
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.